MEM (10 mg/kg) significantly reduced the levels of GSK3β phosphorylated at Ser9, the inactive form of GSK3β (p < 0.001, Figures 7(a) and 7(c)), and increased the levels of p-AKT (p < 0.001, Figures 7(a) and 7(b)), p-JNK (p < 0.01, Figures 7(a) and 7(e)), and p-ERK (p < 0.05, Figures 7(a) and 7(d)) compared to those in CRS-only mice. The gene discussed is MAPK8; the disease is congenital rubella syndrome.